Upadhaya Samik, Reizis Boris, Sawai Catherine M
Graduate Program in Pathobiology and Molecular Medicine, Columbia University Medical Center, New York, NY, USA; Department of Pathology, New York University Langone Medical Center, New York, NY, USA.
Department of Pathology, New York University Langone Medical Center, New York, NY, USA; Department of Medicine, New York University Langone Medical Center, New York, NY, USA.
Exp Hematol. 2018 May;61:26-35. doi: 10.1016/j.exphem.2018.02.004. Epub 2018 Mar 6.
The production of blood cells is dependent on the activity of a rare stem cell population that normally resides in the bone marrow (BM) of the organism. These hematopoietic stem cells (HSCs) have the ability to both self-renew and differentiate, ensuring this lifelong hematopoiesis. Determining the regulation of HSC functions should thus provide critical insight to advancing regenerative medicine. Until quite recently, HSCs were primarily studied using in vitro studies and transplantations into immunodeficient hosts. Indeed, the definition of a bona fide HSC is its ability to reconstitute lymphopenic hosts. In this review, we discuss the development of novel, HSC-specific genetic reporter systems that enable the prospective identification of HSCs and the study of their functions in the absence of transplantation. Coupled with additional technological advances, these studies are now defining the fundamental properties of HSCs in vivo. Furthermore, complex cellular and molecular mechanisms that regulate HSC dormancy, self-renewal, and differentiation are being identified and further dissected. These novel reporter systems represent a major technological advance for the stem cell field and allow new questions to be addressed.
血细胞的生成依赖于一种罕见的干细胞群体的活性,这种干细胞群体通常存在于生物体的骨髓(BM)中。这些造血干细胞(HSCs)具有自我更新和分化的能力,确保了终身造血。因此,确定造血干细胞功能的调控机制对于推进再生医学具有至关重要的意义。直到最近,造血干细胞主要通过体外研究和移植到免疫缺陷宿主中进行研究。事实上,真正的造血干细胞的定义是其重建淋巴细胞减少宿主的能力。在这篇综述中,我们讨论了新型的、造血干细胞特异性基因报告系统的发展,这些系统能够前瞻性地识别造血干细胞,并在不进行移植的情况下研究其功能。结合其他技术进步,这些研究现在正在定义造血干细胞在体内的基本特性。此外,调节造血干细胞休眠、自我更新和分化的复杂细胞和分子机制正在被识别并进一步剖析。这些新型报告系统代表了干细胞领域的一项重大技术进步,并允许解决新的问题。